HIG.TO Holdings
Brompton Global Healthcare Income & Growth ETF
1W: -1.9%
1M: -6.1%
3M: -6.1%
YTD: -10.5%
1Y: -2.4%
3Y: +4.9%
5Y: -9.2%
C$7.24 ($5.08)
-0.02 (-0.28%)
Weekly Expected Move ±2.1%
C$7
C$7
C$7
C$7
C$8
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$37M
Holdings—
Top 10 Wt—%
Beta0.94
% Profitable—%
Coverage93%
Portfolio Valuation
P/E31.2
P/B7.4
P/S2.1
EV/EBITDA19.1
P/FCF23.6
PEG1.58
Profitability & Returns
Gross Margin30.8%
Net Margin6.6%
ROE24.0%
ROA7.6%
ROIC15.8%
Div Yield1.69%
Leverage & Liquidity
Debt/Equity1.01
Debt/Assets0.32
Net Debt/EBITDA1.8x
Interest Cov9.7x
Current Ratio1.05
Quick Ratio0.80
Growth (YoY)
Revenue+10.8%
Net Income+6.6%
EPS+18.6%
FCF+35.5%
EBITDA+1.4%
Rev CAGR 3Y+8.9%
Quality Scores
Piotroski F6.7
Altman Z4.94
IS Quality70.6
IS Overall62.8
IS Value46.8
Median P/E24.1
Sector Breakdown
3 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 23 | 88.6% | 26.6 |
| Other | 2 | 7.0% | — |
| Real Estate | 1 | 4.4% | 118.1 |
Smart Money Overlap
2 holdings with signals
Showing 26 of 26 holdings
· Page 1 of 1
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & Johnson | JNJ | 5.60% | $3.8M | 9,900 | 29.6 | $617.0B | Healthcare |
| 2 | Novartis AG ADR | NVS | 5.40% | $3.6M | 17,776 | 21.3 | $268.0B | Healthcare |
| 3 | Gilead Sciences, Inc. | GILD | 5.40% | $3.6M | 16,959 | -55.7 | $179.5B | Healthcare |
| 4 | Cardinal Health, Inc. | CAH | 5.30% | $3.6M | 11,140 | 31.4 | $53.5B | Healthcare |
| 5 | Bristol-Myers Squibb Company | BMY | 5.20% | $3.5M | 38,978 | 13.5 | $124.9B | Healthcare |
| 6 | Eli Lilly and Company | LLY | 5.20% | $3.5M | 2,078 | 38.2 | $1.1T | Healthcare |
| 7 | Vertex Pharmaceuticals Incorporated | VRTX | 5.00% | $3.4M | 4,477 | 29.1 | $128.1B | Healthcare |
| 8 | Merck & Co Inc. | MRK | 4.90% | $3.3M | 15,797 | 114.5 | $356.4B | Healthcare |
| 9 | UnitedHealth Group Inc. | UNH.NE | 4.50% | $3.0M | 179,267 | 23.9 | $441.4B | Healthcare |
| 10 | McKesson Corp. | MCK | 4.50% | $3.0M | 2,469 | 24.0 | $105.6B | Healthcare |
| 11 | Welltower Inc. | WELL | 4.40% | $3.0M | 9,001 | 118.1 | $164.2B | Real Estate |
| 12 | HCA Healthcare, Inc. | HCA | 4.10% | $2.8M | 4,497 | 14.2 | $92.4B | Healthcare |
| 13 | Agilent Technologies Inc. | A | 4.00% | $2.7M | 10,821 | 33.0 | $47.4B | Healthcare |
| 14 | The Cigna Group Private | — | 3.70% | $2.5M | — | — | — | — |
| 15 | GSK plc | GSK.L | 3.60% | $2.4M | 70,250 | 14.8 | $71.3B | Healthcare |
| 16 | CVS Health Corporation | CVS | 3.40% | $2.3M | 18,642 | 22.6 | $110.3B | Healthcare |
| 17 | Danaher Corporation | DHR | 3.30% | $2.2M | 6,989 | 37.9 | $150.5B | Healthcare |
| 18 | Others Private | — | 3.30% | $2.2M | — | — | — | — |
| 19 | Amgen Inc. | AMGN | 2.90% | $2.0M | 3,237 | 24.8 | $217.5B | Healthcare |
| 20 | Quest Diagnostics Inc. | DGX | 2.80% | $1.9M | 5,623 | 24.4 | $25.7B | Healthcare |
| 21 | Regeneron Pharmaceuticals, Inc. | REGN | 2.50% | $1.7M | 1,566 | 17.6 | $75.7B | Healthcare |
| 22 | AstraZeneca PLC | AZN.L | 2.50% | $1.7M | 7,278 | 23.3 | $184.1B | Healthcare |
| 23 | Edwards Lifesciences Corporation | EW | 2.40% | $1.6M | 13,079 | 48.9 | $49.0B | Healthcare |
| 24 | Thermo Fisher Scientific Inc. | TMO | 2.10% | $1.4M | 1,457 | 35.2 | $242.1B | Healthcare |
| 25 | Cencora, Inc. | COR | 2.00% | $1.3M | 3,117 | 22.9 | $60.1B | Healthcare |
| 26 | Roche Holding AG | RO.SW | 2.00% | $1.3M | 2,196 | 22.5 | $278.9B | Healthcare |